[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100423824":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":57,"collaborators":59,"id":63,"slug":18,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":18,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":18,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of Aarhus","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention (+RFA) arm","EXPERIMENTAL","Preoperative partial RFA necrosis in the liver metastasis followed by liver resection",[13],"Device: RFA (radiofrequency ablation)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control (-RFA) arm","NO_INTERVENTION","Liver resection",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","RFA (radiofrequency ablation)","Preoperative RFA-induced partial necrosis of the liver metastasis",[9],[26],{"name":27,"affiliation":28,"role":29},"Frank V Mortensen, MD, DMSc","Aarhus University Hospital","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Jakob Kirkegård, MD, PhD","CONTACT","+4524995027","jakob.kirkegaard@auh.rm.dk",[37],{"facility":38,"status":39,"city":40,"state":18,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Aarhus University Hospital, Department of Surgery","RECRUITING","Aarhus","8200","Denmark","DK",{"type":45,"coordinates":46},"Point",[47,48],10.21076,56.15674,{"lat":48,"lon":47},[51,52,53,55],{"name":32,"role":33,"phone":18,"phoneExt":18,"email":35},{"name":27,"role":29,"phone":18,"phoneExt":18,"email":18},{"name":32,"role":54,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"name":56,"role":54,"phone":18,"phoneExt":18,"email":18},"Andrea Lund, MD",{"type":58,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[60,61],{"name":28,"class":6},{"name":62,"class":6},"Rigshospitalet, Denmark","100423824",false,"NCT04798898","Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation","ISCOLIM","Inclusion Criteria:\n\n* Patients with colorectal liver metastases planned for resection\n* At least one tumor size \\>=3cm\n* Performance status 0-1\n\nExclusion Criteria:\n\n* Liver cirrhosis\n* Extrahepatic metastases that can not be addressed curatively\n* Other malignant diseases within 5 years prior to diagnosis\n* Prior RFA treatment","ALL","18 Years","99 Years",{"count":73,"type":74},200,"ESTIMATED","INTERVENTIONAL",[77],"NA","To examine radio frequency ablation as a treatment supplement to stimulate immunogenicity and improve survival for patients undergoing curative-intent surgery for colorectal liver metastases.",[80],"Liver Metastasis Colon Cancer","2024-12-04",{"date":83,"type":84},"2024-12-05","ACTUAL",{"date":86,"type":84},"2022-11-14",{"date":88,"type":74},"2026-12-01",{"name":5,"class":6},1]